Skip to main content
Home
Services
About Us
Perspectives
Resources
Publications
Home
Services
About Us
Perspectives
Resources
Publications
Publications
All
Clinical
Innovation
Preclinical
Research
Reviews
Regulations and Science: Common Sense Approaches to Accelerating Patient Access to Novel Gene and Cell Therapies
Innovation
Read more
Inducible nitric oxide is essential for host control of persistent but not acute infection with the intracellular pathogen Toxoplasma gondii.
Research
Read more
Critical roles for the Bcl-3 oncoprotein in T cell-mediated immunity, splenic microarchitecture, and germinal center reactions.
Research
Read more
Perforin-mediated cytolysis plays a limited role in host resistance to Toxoplasma gondii
Research
Read more
Mechanisms of innate resistance to Toxoplasma gondii infection
Reviews
Read more
Analysis of granuloma formation in double cytokine-deficient mice reveals a central role for IL-10 in polarizing both T helper cell 1- and T helper cell 2-type cytokine responses in vivo.
Research
Read more
Leishmania major-infected C3H mice treated with anti-IL-12 mAb develop but do not maintain a Th2 response
Preclinical
Read more
Immune responses in mice deficient in Ly-GDI, a lymphoid-specific regulator of Rho GTPases.
Research
Read more
In vivo microbial stimulation induces rapid CD40 ligand-independent production of interleukin 12 by dendritic cells and their redistribution to T cell areas.
Research
Read more
The role of dendritic cells in the initiation of host resistance to Toxoplasma gondii.
Reviews
Read more
Role of natural killer cells in innate resistance to protozoan infections.
Reviews
Read more
Toxoplasma gondii: evidence for interleukin-12-dependent and-independent pathways of interferon-gamma production induced by an attenuated parasite strain.
Research
Read more
In the absence of endogenous IFN-gamma, mice develop unimpaired IL-12 responses to Toxoplasma gondii while failing to control acute infection.
Preclinical
Read more
Natural killer cells are a source of interferon gamma that drives differentiation of CD4+ T cell subsets and induces early resistance to Leishmania major in mice.
Preclinical
Read more
The adjuvant effect of interleukin-12 in a vaccine against Leishmania major.
Preclinical
Read more
Interaction between the innate and the acquired immune system following infection of different mouse strains with Leishmania major
Reviews
Read more
The role of the innate immune response in Th1 cell development following Leishmania major infection
Research
Read more
IL-12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental leishmaniasis.
Preclinical
Read more
Interferon consensus sequence binding protein-deficient mice display impaired resistance to intracellular infection due to a primary defect in interleukin 12 p40 induction.
Research
Read more
In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha.
Preclinical
Read more
A role for CD4+ NK1.1+ T lymphocytes as major histocompatibility complex class II independent helper cells in the generation of CD8+ effector function against intracellular infection.
Research
Read more
The role of IL-12 in regulation of T helper cell subsets in vivo. Lessons from experimental cutaneous leishmaniasis
Reviews
Read more
Cytokines as determinants of disease and disease interactions.
Reviews
Read more
Mice deficient in nuclear factor (NF)-kappa B/p52 present with defects in humoral responses, germinal center reactions, and splenic microarchitecture.
Research
Read more
Transcutaneous immunization using colonization factor and heat-labile enterotoxin induces correlates of protective immunity for enterotoxigenic Escherichia coli.
Preclinical
Read more
Transcutaneous immunization with bacterial ADP-ribosylating exotoxins, subunits, and unrelated adjuvants.
Preclinical
Read more
Transcutaneous immunization of domestic animals: opportunities and challenges.
Reviews
Read more
GLP Requirements and Current Practices
Preclinical
Read more
Designing Labs for Lean Operation
Reviews
Read more
Incorporating Lean Principles into Pharmaceutical QC Laboratory Design: building design influencing laboratory behaviours and effectiveness
Innovation
Read more
Strategies for Facilitating Regulatory Pathways
Innovation
Read more
The vaccines consistency approach project: an EPAA initiative
Innovation
Read more
Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe
Clinical
Read more
Dry Formulation for Transcutaneous Immunization.
Innovation
Read more
Transcutaneous Immunization for Enteric Vaccines
Innovation
Read more
Principles of transcutaneous immunization using cholera toxin as an adjuvant
Reviews
Read more
Decreased resistance of TNF receptor p55- and p75-deficient mice to chronic toxoplasmosis despite normal activation of inducible nitric oxide synthase in vivo.
Research
Read more
Infection of mice lacking the common cytokine receptor gamma-chain (gamma(c)) reveals an unexpected role for CD4+ T lymphocytes in early IFN-gamma-dependent resistance to Toxoplasma gondii.
Research
Read more
Partially protective vaccination permits the development of latency in a normally virulent strain of Toxoplasma gondii.
Preclinical
Read more
Genetic immunization with glycoprotein 63 cDNA results in a helper T cell type 1 immune response and protection in a murine model of leishmaniasis
Research
Read more
Failure of P strain mice to respond to vaccination against schistosomiasis correlates with impaired production of IL-12 and up-regulation of Th2 cytokines that inhibit macrophage activation.
Research
Read more
Transcutaneous immunization with cholera toxin protects mice against lethal mucosal toxin challenge
Preclinical
Read more
Transcutaneous immunization with bacterial ADP-ribosylating exotoxins as antigens and adjuvants
Research
Read more
Advances in vaccine delivery: transcutaneous immunisation
Reviews
Read more
Immunostimulatory oligodeoxynucleotides promote protective immunity and provide systemic therapy for leishmaniasis via IL-12- and IFN-gamma-dependent mechanisms
Research
Read more
Pre-Approval Access: Can Compassion, Business, and Medicine Coexist?
Innovation
Read more